Long-term protective potency of AAV vector-based SARS-CoV-2 prophylaxis in mice and non-human primates
IntroductionRecombinant adeno-associated virus (rAAV)-mediated delivery of neutralizing antibodies is a promising strategy for rapid and durable prophylaxis against SARS-CoV-2.MethodsWe evaluated the long-term expression, pharmacokinetics, immunogenici…